Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The emerging role of retinoids and retinoic acid metabolism blocking agents in the treatment of cancer.

Cancer - 15 Oct 1998

Miller W H

Abstract excerpt

BACKGROUND: Although significant advances have been made in the treatment of some malignancies, the prognosis of patients with metastatic tumors remains poor. Differentiating agents redirect cells toward their normal phenotype and therefore may reverse or suppress evolving malignant lesions or pr...

Topics

Antineoplastic Agents
Cell Differentiation
Chemoprevention
Cytochrome P-450 Enzyme Inhibitors
Drug Resistance, Neoplasm
Enzyme Inhibitors
Humans
Imidazoles
Neoplasms
Phenotype
Receptors, Retinoic Acid
Retinoids

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Tretinoin

Source

Identifiers

PMID: 9781940
DOI: 10.1002/(sici)1097-0142(19981015)83:8<1471::aid-cncr1>3.0.co;2-6

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 30 Aug 2026. Prepared record publication-9781940-2026-08-30.1. Manifest publication-graph-cohort-2026-08-30.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 30 Aug 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The emerging role of retinoids and retinoic acid metabolism blocking agents in the treatment of cancer.PMID 9781940Read ↗

The Rb Pathway and Cancer TherapeuticsSemantic proximity Read ↗

Why Differentiation Therapy Sometimes Fails: Molecular Mechanisms of Resistance to RetinoidsSemantic proximity Read ↗

Retinoids: present role and future potentialSemantic proximity Read ↗

Targeting the RB-pathway in Cancer TherapySemantic proximity Read ↗

Traffic lights for retinoids in oncology: molecular markers of retinoid resistance and sensitivity and their use in the management of cancer differentiation therapySemantic proximity Read ↗

Retinoids in biological control and cancerSemantic proximity Read ↗

Enhancing Retinoic Acid-mediated Effects Through Inhibition of CYP26A1, CYP26B1 and HGF Signaling in Neuroblastoma CellsSemantic proximity Read ↗

Unlocking the potential of retinoic acid in anticancer therapySemantic proximity Read ↗

Overcoming microenvironment-mediated protection from ATRA using CYP26-resistant retinoidsSemantic proximity Read ↗

Revealing a natural marine product as a novel agonist for retinoic acid receptors with a unique binding mode and inhibitory effects on cancer cellsSemantic proximity Read ↗

Retinoic acid enhances sensitivity of neuroblastoma cells for imatinib mesylate.Semantic proximity Read ↗

Retinoic Acid affects Lung Adenocarcinoma growth by inducing differentiation via GATA6 activation and EGFR and Wnt inhibitionSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.